23andMe Holding Co. (ME) vs DENTSPLY SIRONA Inc. (XRAY)

XRAY leads on 6 of 9 compared metrics.

A side-by-side comparison of 23andMe Holding Co. and DENTSPLY SIRONA Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 13, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

Total return — ME vs XRAY

growth of $100 · last 5y
ME -99.7%XRAY -72.2%XRAY compounded faster
Log scale — wide-divergence pair
01101001kStart $100202120222023202420252026$0$28
ME XRAY

ME vs XRAY: by the numbers

  • XRAY is the larger company ($2.02B vs $15M market cap).
  • Both run net losses; XRAY's is the smaller (-17.06% vs -134.54% net margin).
  • XRAY grew revenue faster over the past five years (1.12% vs -9.07% CAGR).
  • XRAY pays a dividend (4.76% yield) while ME does not currently pay one.

Which is better, ME or XRAY?

Metric tally: ME 3 · XRAY 6

It depends on what you're optimizing for:

GrowthXRAY(faster 5Y revenue CAGR)
QualityXRAY(higher ROIC)

Valuation

MetricMEXRAY
Forward P/E7.11
P/S ratio0.100.55
P/B ratio0.511.53
FCF yield5.16%

Profitability

MetricMEXRAY
Gross margin53.33%48.93%
Operating margin-114.00%5.87%
Net margin-134.54%-17.06%
ROE-721.75%-47.65%
ROIC-553.10%5.67%

Dividends

MetricMEXRAY
Dividend yield4.76%

Growth (annualized)

MetricMEXRAY
Revenue CAGR (5Y)-9.07%1.12%
EPS CAGR (5Y)-0.93%
FCF CAGR (5Y)-29.96%
Total return CAGR (5Y)-68.93%-29.72%

Frequently asked

Which is better, ME or XRAY?
It depends on your goal. growth: XRAY (faster 5Y revenue CAGR); quality: XRAY (higher ROIC). Across all compared metrics, XRAY leads 6 to 3.
Which has grown faster, ME or XRAY?
Over the past five years, XRAY grew revenue faster — ME at a -9.07% CAGR versus XRAY at 1.12%.
Does ME or XRAY pay a bigger dividend?
XRAY pays a dividend (4.76% yield) while ME does not currently pay one.
Which has been the better investment, ME or XRAY?
Over the past 5-year, XRAY delivered the higher annualized total return — ME at -68.93% versus XRAY at -15.61%. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 13, 2026.